Child and Adolescent NeuroDevelopment Initiative (CANDI)
CANDI is dedicated to biomarker discovery, neuroimaging, and treatment studies of individuals with neurodevelopmental disorders and intellectual and developmental disabilities including autism and fragile X.
The Child and Adolescent NeuroDevelopment Initiative (CANDI) is a research division of the Eunice Kennedy Shriver Center at the University of Massachusetts Chan Medical School and is dedicated to biomarker discovery, neuroimaging, and treatment studies of individuals with neurodevelopmental disorders and intellectual and developmental disabilities, including autism and fragile X.
The Neurobehavioral Technologies program led by Dr. David M Cochran, is also housed within CANDI.
The CANDI team is led by Dr. Jean A Frazier and Dr. David N Kennedy and is supported by child psychiatrists, neuropsychologists, statisticians, research coordinators, psychologists, and interested volunteers.
CANDI works closely with:
- Asperger/Autism Network (AANE)
- Autism Resource Central
- Autism Speaks
- The Child and Adolescent Psychiatry Residency Program
- Community Healthlink Youth & Family Services
- FRAXA Research Foundation
- National Fragile X Foundation
- Fragile X LINKS Group of Eastern Massachusetts
- Parent/Professional Advocacy League
- Child & Adolescent Psychiatry at UMass Memorial Medical Center
- The UMass Memorial Children’s Medical Center
Find us on Facebook and Twitter.
Please see our video about our work in CANDI.
Learn more about the CANDI active research studies.
Learn more about the results from the past CANDI research studies.
Education & Training
CANDI Education & Training
We supervise and educate many individuals at various stages of their research training, including residents, fellows, graduate students, medical students, as well as college and high school students.